GLPwatch
Diabetes medications improve cardiovascular outcomes: the paradigm shifts.
Curr Opin Lipidol · 2016
Last updated 2026-05-28| Journal | Curr Opin Lipidol, 2016 |
|---|---|
| Citations | 0 |
| Relative citation ratio | 0.00 |
| NIH percentile | 0 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes, Cardiovascular Risk Reduction |
Full record and abstract on PubMed 27805974 ↗